✦ LIBER ✦

A new case of malonyl coenzyme A decarboxylase deficiency presenting with cardiomyopathy

✍ Scribed by S. Yano; L. Sweetman; D. R. Thorburn; S. Mofidi; J. C. Williams

Publisher: Springer
Year: 1997
Tongue: English
Weight: 66 KB
Volume: 156
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s004310050619

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical, enzymatic and molecular charac

Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency

✍ G. S. Salomons; C. Jakobs; L. Landegge Pope; A. Errami; M. Potter; M. Nowaczyk; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 327 KB

A new infantile case of α-N-acetylgalact

A new infantile case of α-N-acetylgalactosaminidase deficiency. Cardiomyopathy as a presenting symptom

✍ A. Chabás; J. Duque; L. Gort 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 172 KB

Malonyl coenzyme A decarboxylase deficie

Malonyl coenzyme A decarboxylase deficiency. Clinical and biochemical findings in a second child with a more severe enzyme defect

✍ E. A. Haan; R. D. Scholem; H. B. Croll; G. K. Brown 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 454 KB

Cardiomyopathy and Hypotonia in a 5-Mont

Cardiomyopathy and Hypotonia in a 5-Month-Old Infant with Malonyl-CoA Decarboxylase Deficiency: Potential for Preclinical Diagnosis with Expanded Newborn Screening

✍ C. Ficicioglu; M. R. K. Chrisant; I. Payan; D.H. Chace 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 76 KB

A new case of 3-hydroxy-3-methylglutaryl

A new case of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency

✍ E. Marklová; P. Verner; F. Pehal; M. Brátová; J. Polák 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 73 KB

Design and synthesis of a new class of m

Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities

✍ Haifeng Tang; Yan Yan; Zhe Feng; Reynalda K. de Jesus; Lihu Yang; Dorothy A. Lev 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 363 KB

A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elev